Botulinum toxin type A (Dysport) has been recommended for listing on the PBS for treatment of focal spasticity of the lower limb (LLFS) following stroke or other acute neurological event. The recommendation is for a Section 100 (Botulinum Toxin Program) Authority Required (STREAMLINED) listing for the treatment of patients with moderate to severe LLFS. The ...
Dysport recommended for LLFS listing on PBS
29 Aug 2019